Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
British Journal of Haematology
|
March 10, 2005
Defining stroke risk in children with sickle cell anaemia
Carolyn Hoppe
Hematology/Oncology Clinics of North America
|
April 30, 2019
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development
Carolyn Hoppe, Lynne Neumayr
Pediatric Clinics of North America
|
February 13, 2003
Pediatric thrombosis
Carolyn Hoppe, Alison Matsunaga
Pediatric Blood & Cancer
|
January 3, 2013
Potential role for statins in sickle cell disease
Soheir S Adam, Carolyn Hoppe
Blood Cells, Molecules & Diseases
|
August 29, 2017
The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies
Patrick T McGann, Carolyn Hoppe
British Journal of Haematology
|
May 14, 2015
How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease
Kate Gardner, Carolyn Hoppe, Aleksandar Mijovic, et al.
American Journal of Hematology
|
December 1, 2010
Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease
Elsie Gyang, Kristen Yeom, Carolyn Hoppe, et al.
Blood Cells, Molecules & Diseases
|
December 7, 2013
Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease
Marion E Reid, Christine Halter Hipsky, Kim Hue-Roye, et al.
British Journal of Haematology
|
April 4, 2017
Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial
Carolyn Hoppe, Eufemia Jacob, Lori Styles, et al.
British Journal of Haematology
|
April 12, 2011
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction
Carolyn Hoppe, Frans Kuypers, Sandra Larkin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
British Journal of Haematology
|
March 10, 2005
Defining stroke risk in children with sickle cell anaemia
Carolyn Hoppe
Hematology/Oncology Clinics of North America
|
April 30, 2019
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development
Carolyn Hoppe, Lynne Neumayr
Pediatric Clinics of North America
|
February 13, 2003
Pediatric thrombosis
Carolyn Hoppe, Alison Matsunaga
Pediatric Blood & Cancer
|
January 3, 2013
Potential role for statins in sickle cell disease
Soheir S Adam, Carolyn Hoppe
Blood Cells, Molecules & Diseases
|
August 29, 2017
The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies
Patrick T McGann, Carolyn Hoppe
British Journal of Haematology
|
May 14, 2015
How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease
Kate Gardner, Carolyn Hoppe, Aleksandar Mijovic, et al.
American Journal of Hematology
|
December 1, 2010
Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease
Elsie Gyang, Kristen Yeom, Carolyn Hoppe, et al.
Blood Cells, Molecules & Diseases
|
December 7, 2013
Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease
Marion E Reid, Christine Halter Hipsky, Kim Hue-Roye, et al.
British Journal of Haematology
|
April 4, 2017
Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial
Carolyn Hoppe, Eufemia Jacob, Lori Styles, et al.
British Journal of Haematology
|
April 12, 2011
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction
Carolyn Hoppe, Frans Kuypers, Sandra Larkin, et al.
Page
of 4